Supernus Pharmaceuticals Stock Predictions

Mode Mobile Could be Next in Line"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

SUPN
Supernus Pharmaceuticals

Last Price:

$30.72

Seasonality Move:

13.42%

7 Day Trial

ALL ACCESS PASS

$ 7

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Supernus Pharmaceuticals Stock Forecast

Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 23.6% based on the past 12 years of stock performance.
Supernus Pharmaceuticals has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Is Supernus Pharmaceuticals Stock Undervalued?

The current Supernus Pharmaceuticals [SUPN] share price is $30.71. The Score for SUPN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
SUPN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Supernus Pharmaceuticals Stock Go Up Next Year?

Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 23.6% based on the past 12 years of stock performance.

Supernus Pharmaceuticals Stock Rating

Sell

Supernus Pharmaceuticals (SUPN) is a Sell

Is Supernus Pharmaceuticals overpriced?

Supernus Pharmaceuticals has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Supernus Pharmaceuticals Stock Price History

Is SUPN stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SUPN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

supernus.com

52-Week Data

52-Week High:

40.28

52-Week Low:

25.53

Prediction Charts

Market Cap:

1.7B

Price in USD:

30.71

Volume:

357.8K

Beta:

1.09

Technical Analysis

SMA50:

33.60

SMA100:

35.32

SMA200:

33.69

52-Wk Change:

4.35%

Stock Predictions

Is Supernus Pharmaceuticals stock public?

Yes, Supernus Pharmaceuticals is a publicly traded company.
What is the Supernus Pharmaceuticals stock quote today?

The Supernus Pharmaceuticals stock price is 30.71 USD today.
How to buy Supernus Pharmaceuticals stock online?

You can buy Supernus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Mar-28	32.46	32.29	32.46	32.10
Mar-31	32.11	32.75	32.87	31.64
Apr-1	32.48	31.68	32.66	31.38
Apr-2	31.42	32.82	32.93	31.13
Apr-3	32.01	32.49	32.84	32.01
Apr-4	31.68	32.74	33.35	31.43
Apr-7	32.15	32.27	34.26	31.97
Apr-8	32.75	30.64	33.14	30.24
Apr-9	30.00	31.76	32.05	29.77
Apr-10	31.37	31.07	31.55	30.11
Apr-11	31.23	31.67	31.68	30.60
Apr-14	31.98	31.60	32.28	31.42
Apr-15	31.95	31.46	32.28	31.21
Apr-16	32.10	30.71	32.10	30.59

Supernus Pharmaceuticals Earnings

Supernus Pharmaceuticals Earnings Report: Per Share Supernus Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Supernus Pharmaceuticals Forecast Revenue Growth

Supernus Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Supernus Pharmaceuticals and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.91 per share, and an increase next year of $0.58 per share.

* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.